April 19, 2016
Article
The explosion of new drugs for the treatment of castration-resistant prostate cancer (CRPC) is a welcome advance, but raises questions about how best to sequence these drugs with standard docetaxel chemotherapy.
October 21, 2015
Article
Hypofractionated radiotherapy can achieve similar cure rates with similar side effects compared with conventional radiotherapy for men with low-risk, early prostate cancer, according to a recent study.
October 20, 2015
Article
A phase III study shows noninferiority of accelerated partial breast irradiation as compared to conventional whole breast irradiation.
October 19, 2015
Article
Hypofractionation, known as delivering higher doses of radiation in fewer fractions, appears to be feasible and non-inferior compared with conventional fractionated radiotherapy.